Bayer reloads Leaps with €1.3 billion to step up investments in biotech innovation - MedCity News

Over the past seven years, Bayer's investment arm has infused 50-plus companies with more than €1.3 billion. Leaps by Bayer is accelerating its dealmaking pace and Bayer is committing another €1.3 billion, which the multinational corporation estimates will fuel its investment vehicle for two more years. Bayer announced the capital commitment on Friday during the company's Breakthrough Innovation Forum, an event that covered the corporation's plans in healthcare and agriculture. Those two fields were the core focus areas when Bayer formed Leaps in 2015, aiming to invest in companies developing breakthrough solutions to big challenges facing humanity, challenges that the corporation termed "leaps." At the start, Bayer identified 10 leaps.